Remaining Unmet Technical and Clinical Needs in TAVR: Opportunities for Innovation to Improve Clinical Outcomes
We Recommend
Disclosures
Within the past 12 months, I or my spouse/partner have had a financial interest/arrangement or affiliation with the organization(s) listed below:
- Consultant Fee/Honoraria/Speaker's Bureau (Personal) - Abbott Vascular; Medtronic; Edwards Lifesciences; NeoChord; Supira; CorFlow; PiCardia; Boston Scientific Corporation